Zombie NIR™ Fixable Viability Kit Zombie NIR™ Fixable Viability Kit

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixable Dye, Fixable Viability Dye, Dead, Apoptosis
Ave. Rating
Submit a Review
Product Citations
publications
Zombie_NIR_Antibody_FC_062413
One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
  • Zombie_NIR_Antibody_FC_062413
    One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
See Zombie NIR™ spectral data
Cat # Size Price Quantity Check Availability Save
423105 100 tests DKK529
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423106 500 tests DKK1990
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Zombie NIR™ is an amine reactive fluorescent dye that is non-permeant to live cells, but permeant to the cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie NIR™ is a polar water soluble dye, providing red fluorescence, making it suitable for multi-color detection.

Product Details
Technical Data Sheet (pdf)

Product Details

Preparation
Zombie NIR™ Fixable Viability kit is composed of lyophilized Zombie NIR™ dye and anhydrous DMSO. For reconstitution, bring the kit to room temperature; add 100 µl of DMSO to one vial of Zombie NIR™ dye until fully dissolved. 100 tests = 1 vial of Zombie NIR™ + DMSO, 500 tests = 5 vials of Zombie NIR™ + DMSO.
Storage & Handling
Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie NIR™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.
Application

FC - Quality tested

Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis.

For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.

Excitation Laser
Red Laser (633 nm)
Application Notes

Zombie NIR™ dye is excited by the red laser and has fluorescence emission maximum at 746 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie NIR™ dye has similar emission to APC/Cyanine7.

Standard Cell Staining Protocol:

  1. Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrifuge to ensure the reagent is at the bottom of the vial.
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully dissolved
  3. Wash cells with PBS buffer (no Tris buffer and protein free).
  4. Dilute Zombie NIR™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µL Zombie NIR™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µL for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  5. Incubate the cells at room temperature (or 4°C), in the dark, for 15-30 minutes.
  6. Wash one time with 2 mL BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA.
  7. Continue performing antibody staining procedure as desired.
  8. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation.

No-wash Sequential Staining Protocol:

  1. Wash cells with PBS buffer (no Tris buffer and protein free).
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully  dissolved
  3. Determine the total µL volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µL. Subtract that antibody volume from the 100 µL total staining volume intended for the assay. In the remaining volume, dilute Zombie NIR™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µL of antibody cocktail for a 100 µL total staining volume, use 80 µL of Zombie NIR™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie NIR™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  4. Incubate for 10-15 minutes at RT (or 4°C), protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes.
  5. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet.
  6. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells.
    • Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie NIR™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie NIR™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie NIR™.
Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. McMaster SR, et al. 2015. PLoS One. 10:115725. PubMed
  2. Prado-Garcia H, et al. 2015. Anticancer Res.35:1529. PubMed
  3. Rodriguez-Rodriguez N, et al. 2015. J Immunol. 194:4207. PubMed
  4. Flies DB, et al. 2015. J Immunol. 194:5294. PubMed
Product Citations
  1. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  2. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  3. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  4. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  5. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  6. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  7. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  8. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  9. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  10. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  11. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  12. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  13. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  14. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  15. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  16. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  17. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  18. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  19. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  20. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  21. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  22. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  23. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  24. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  25. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  26. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  27. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  28. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  29. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  30. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  31. Pleuger C, et al. 2022. Elife. 11: . PubMed
  32. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  33. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  34. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  35. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  36. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  37. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  38. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  39. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  40. Rosain J, et al. 2023. Cell. 186:621. PubMed
  41. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  42. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  43. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  44. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  45. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  46. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  47. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  48. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  49. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  50. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  51. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  52. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  53. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  54. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  55. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  56. Zhao Y, et al. 2022. J Neurosci. . PubMed
  57. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  58. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  59. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  60. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  61. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  62. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  63. Han X, et al. 2022. Nutrients. 14:. PubMed
  64. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  65. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  66. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  67. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  68. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  69. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  70. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  71. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  72. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  73. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  74. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  75. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  76. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  77. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  78. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  79. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  80. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  81. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  82. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  83. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  84. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  85. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  86. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  87. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  88. Imai H, et al. 2023. iScience. 26:106822. PubMed
  89. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  90. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  91. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  92. Wu L, et al. 2023. Cell Res. . PubMed
  93. Cansever D, et al. 2023. Nat Immunol. . PubMed
  94. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  95. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  96. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  97. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  98. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  99. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  100. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  101. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  102. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  103. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  104. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  105. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  106. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  107. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  108. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  109. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  110. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  111. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  112. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  113. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  114. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  115. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  116. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  117. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  118. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  119. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  120. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  121. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  122. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  123. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  124. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  125. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  126. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  127. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  128. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  129. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  130. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  131. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  132. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  133. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  134. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  135. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  136. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  137. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  138. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  139. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  140. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  141. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  142. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  143. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  144. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  145. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  146. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  147. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  148. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  149. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  150. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  151. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  152. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  153. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  154. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  155. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  156. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  157. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  158. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  159. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  160. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  161. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  162. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  163. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  164. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  165. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  166. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  167. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  168. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  169. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  170. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  171. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  172. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  173. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  174. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  175. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  176. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  177. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  178. Woodruff MC, et al. 2022. Nature. :. PubMed
  179. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  180. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  181. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  182. Akiyama H, et al. 2020. J Virol. . PubMed
  183. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  184. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  185. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  186. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  187. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  188. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  189. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  190. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  191. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  192. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  193. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  194. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  195. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  196. Mills C, et al. 2022. Cells. 11:. PubMed
  197. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  198. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  199. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  200. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  201. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  202. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  203. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  204. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  205. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  206. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  207. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  208. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  209. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  210. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  211. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  212. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  213. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  214. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  215. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  216. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  217. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  218. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  219. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  220. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  221. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  222. Wang Z, et al. 2021. bioRxiv. . PubMed
  223. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  224. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  225. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  226. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  227. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  228. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  229. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  230. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  231. English KG, et al. 2022. Biomedicines. 10:. PubMed
  232. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  233. Woodruff M, et al. 2020. medRxiv. . PubMed
  234. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  235. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  236. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  237. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  238. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  239. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  240. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  241. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  242. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  243. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  244. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  245. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  246. Popay TM, et al. 2021. Elife. 10: . PubMed
  247. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  248. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  249. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  250. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  251. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  252. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  253. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  254. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  255. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  256. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  257. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  258. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  259. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  260. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  261. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  262. Ito Y, et al. 2018. Cell. 174:636. PubMed
  263. Elias G, et al. 2022. Elife. 11:. PubMed
  264. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  265. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  266. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  267. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  268. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  269. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  270. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  271. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  272. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  273. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  274. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  275. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  276. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  277. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  278. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  279. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  280. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  281. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  283. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  284. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  285. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  286. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  287. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  288. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  289. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  290. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  291. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  292. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  293. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  294. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  295. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  296. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  297. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  298. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  299. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  300. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  301. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  302. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  303. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  304. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  305. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  306. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  307. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  308. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  309. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  310. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  311. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  312. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  313. Wang Z, et al. 2021. Nature. 592:616. PubMed
  314. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  315. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  316. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  317. Dudek M, et al. 2021. Nature. 592:444. PubMed
  318. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  319. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  320. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  321. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  322. He Y, et al. 2022. Cells. 11:. PubMed
  323. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  324. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  325. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  326. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  327. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  328. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  329. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  330. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  331. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  332. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  333. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  334. Wang Z, et al. 2021. Nature. 595:426. PubMed
  335. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  336. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  337. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  338. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  339. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  340. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  341. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  342. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  343. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  344. Korin B, et al. 2020. Sleep. :43. PubMed
  345. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  346. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  347. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  348. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  349. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  350. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  351. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  352. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  353. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  354. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  355. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  356. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  357. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  358. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  359. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  360. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  361. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  362. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  363. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  364. Gaebler C, et al. 2020. bioRxiv. . PubMed
  365. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  366. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  367. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  368. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  369. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  370. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  371. Viant C, et al. 2020. Cell. 183:1298. PubMed
  372. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  373. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  374. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  375. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  376. Sibler E, et al. 2021. Cells. 10:. PubMed
  377. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  378. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  379. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  380. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  381. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  382. Spath S, et al. 2022. iScience. 25:104998. PubMed
  383. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  384. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  385. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  386. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  387. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  388. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed
  389. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  390. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  391. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  392. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  393. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  394. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  395. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  396. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  397. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  398. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  399. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  400. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  401. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  402. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  403. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  404. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  405. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  406. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  407. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  408. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  409. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  410. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  411. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  412. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  413. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  414. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  415. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  416. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  417. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  418. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  419. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  420. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  421. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  422. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  423. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  424. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  425. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  426. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  427. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  428. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  429. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  430. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  431. Pleuger C, et al. 2022. Elife. 11: . PubMed
  432. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  433. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  434. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  435. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  436. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  437. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  438. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  439. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  440. Rosain J, et al. 2023. Cell. 186:621. PubMed
  441. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  442. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  443. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  444. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  445. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  446. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  447. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  448. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  449. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  450. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  451. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  452. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  453. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  454. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  455. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  456. Zhao Y, et al. 2022. J Neurosci. . PubMed
  457. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  458. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  459. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  460. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  461. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  462. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  463. Han X, et al. 2022. Nutrients. 14:. PubMed
  464. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  465. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  466. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  467. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  468. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  469. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  470. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  471. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  472. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  473. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  474. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  475. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  476. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  477. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  478. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  479. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  480. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  481. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  482. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  483. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  484. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  485. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  486. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  487. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  488. Imai H, et al. 2023. iScience. 26:106822. PubMed
  489. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  490. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  491. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  492. Wu L, et al. 2023. Cell Res. . PubMed
  493. Cansever D, et al. 2023. Nat Immunol. . PubMed
  494. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  495. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  496. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  497. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  498. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  499. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  500. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  501. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  502. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  503. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  504. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  505. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  506. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  507. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  508. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  509. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  510. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  511. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  512. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  513. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  514. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  515. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  516. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  517. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  518. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  519. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  520. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  521. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  522. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  523. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  524. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  525. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  526. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  527. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  528. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  529. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  530. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  531. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  532. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  533. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  534. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  535. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  536. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  537. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  538. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  539. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  540. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  541. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  542. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  543. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  544. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  545. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  546. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  547. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  548. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  549. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  550. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  551. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  552. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  553. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  554. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  555. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  556. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  557. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  558. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  559. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  560. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  561. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  562. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  563. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  564. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  565. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  566. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  567. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  568. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  569. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  570. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  571. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  572. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  573. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  574. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  575. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  576. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  577. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  578. Woodruff MC, et al. 2022. Nature. :. PubMed
  579. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  580. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  581. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  582. Akiyama H, et al. 2020. J Virol. . PubMed
  583. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  584. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  585. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  586. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  587. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  588. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  589. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  590. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  591. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  592. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  593. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  594. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  595. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  596. Mills C, et al. 2022. Cells. 11:. PubMed
  597. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  598. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  599. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  600. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  601. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  602. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  603. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  604. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  605. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  606. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  607. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  608. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  609. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  610. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  611. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  612. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  613. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  614. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  615. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  616. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  617. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  618. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  619. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  620. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  621. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  622. Wang Z, et al. 2021. bioRxiv. . PubMed
  623. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  624. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  625. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  626. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  627. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  628. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  629. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  630. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  631. English KG, et al. 2022. Biomedicines. 10:. PubMed
  632. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  633. Woodruff M, et al. 2020. medRxiv. . PubMed
  634. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  635. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  636. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  637. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  638. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  639. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  640. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  641. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  642. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  643. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  644. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  645. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  646. Popay TM, et al. 2021. Elife. 10: . PubMed
  647. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  648. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  649. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  650. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  651. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  652. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  653. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  654. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  655. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  656. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  657. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  658. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  659. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  660. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  661. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  662. Ito Y, et al. 2018. Cell. 174:636. PubMed
  663. Elias G, et al. 2022. Elife. 11:. PubMed
  664. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  665. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  666. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  667. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  668. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  669. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  670. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  671. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  672. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  673. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  674. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  675. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  676. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  677. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  678. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  679. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  680. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  681. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  682. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  683. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  684. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  685. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  686. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  687. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  688. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  689. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  690. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  691. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  692. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  693. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  694. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  695. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  696. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  697. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  698. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  699. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  700. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  701. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  702. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  703. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  704. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  705. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  706. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  707. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  708. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  709. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  710. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  711. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  712. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  713. Wang Z, et al. 2021. Nature. 592:616. PubMed
  714. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  715. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  716. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  717. Dudek M, et al. 2021. Nature. 592:444. PubMed
  718. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  719. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  720. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  721. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  722. He Y, et al. 2022. Cells. 11:. PubMed
  723. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  724. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  725. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  726. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  727. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  728. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  729. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  730. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  731. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  732. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  733. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  734. Wang Z, et al. 2021. Nature. 595:426. PubMed
  735. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  736. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  737. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  738. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  739. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  740. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  741. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  742. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  743. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  744. Korin B, et al. 2020. Sleep. :43. PubMed
  745. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  746. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  747. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  748. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  749. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  750. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  751. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  752. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  753. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  754. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  755. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  756. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  757. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  758. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  759. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  760. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  761. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  762. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  763. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  764. Gaebler C, et al. 2020. bioRxiv. . PubMed
  765. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  766. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  767. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  768. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  769. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  770. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  771. Viant C, et al. 2020. Cell. 183:1298. PubMed
  772. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  773. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  774. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  775. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  776. Sibler E, et al. 2021. Cells. 10:. PubMed
  777. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  778. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  779. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  780. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  781. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  782. Spath S, et al. 2022. iScience. 25:104998. PubMed
  783. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  784. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  785. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  786. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  787. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  788. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed
  789. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  790. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  791. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  792. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  793. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  794. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  795. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  796. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  797. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  798. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  799. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  800. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
NA

Related FAQs

I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
How does the performance of your Zombie dye compare with competitors?

Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.

Can I use methanol/ethanol for fixation after using a Zombie dye?

Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.

Can Zombie be used to determine bacteria, yeast viability?
We have not tested in house bacterial or yeast viability using Zombie dyes. It is not clear whether the difference between surface and intracellular signals will be significantly different in case of non mammalian cells.
Can I use Zombie with cells suspension containing serum?
Serum is full of proteins which will sequester the dye and thereby reducing its effective concentration. The basic rule of thumb with zombie is to titrate it based on your specific condition. Titration also helps reduce the background and spillover into other channels.
Can I use Zombie dyes for microscopy?

Zombie dyes tested in-house for microscopy applications will display data on the product technical datasheet. It should be noted that Zombie dyes may not work for dead cell discrimination in every microscopy application. Important considerations that may impact analysis are determining the signal level that constitutes a dead cell and identifying the proper plane to observe the dead cells.

Why can't I fix my cells prior to using Zombie dyes?

The fixation process can contort and alter the membrane of cells, effectively rendering them dead. Since the ability of the Zombie dyes to stain dead cells is correlated with cell permeability, your results may no longer be a valid representation of dead versus live cells.

Can I use Zombie dyes to detect apoptotic cells?

Yes, Zombie dyes can be used with apoptosis markers, such as Annexin V or Apotracker™ (shown below), to discriminate live, apoptotic, and dead cells.

One day-old C57BL/6 mouse thymocytes were stained with Apotracker™ Tetra Alexa Fluor® 647 and Zombie™ YG581. Zombie-dim/Apotracker™-positive cells are apoptotic, while double-positive cells are dead. Live cells are negative for both markers.

How should I store Zombie dyes?

Store the Zombie dye kit at -20°C upon receipt. Do not open vials until needed. Once DMSO is added, use immediately or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.

Go To Top Version: 7    Revision Date: 12/18/2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixable Dye, Fixable Viability Dye, Dead, Apoptosis
Ave. Rating
Submit a Review
Product Citations
publications
Zombie_NIR_Antibody_FC_062413
One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
  • Zombie_NIR_Antibody_FC_062413
    One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
See Zombie NIR™ spectral data
Cat # Size Price Quantity Check Availability Save
423105 100 tests DKK529
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423106 500 tests DKK1990
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Zombie NIR™ is an amine reactive fluorescent dye that is non-permeant to live cells, but permeant to the cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie NIR™ is a polar water soluble dye, providing red fluorescence, making it suitable for multi-color detection.

Product Details
Technical Data Sheet (pdf)

Product Details

Preparation
Zombie NIR™ Fixable Viability kit is composed of lyophilized Zombie NIR™ dye and anhydrous DMSO. For reconstitution, bring the kit to room temperature; add 100 µl of DMSO to one vial of Zombie NIR™ dye until fully dissolved. 100 tests = 1 vial of Zombie NIR™ + DMSO, 500 tests = 5 vials of Zombie NIR™ + DMSO.
Storage & Handling
Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie NIR™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.
Application

FC - Quality tested

Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis.

For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.

Excitation Laser
Red Laser (633 nm)
Application Notes

Zombie NIR™ dye is excited by the red laser and has fluorescence emission maximum at 746 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie NIR™ dye has similar emission to APC/Cyanine7.

Standard Cell Staining Protocol:

  1. Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrifuge to ensure the reagent is at the bottom of the vial.
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully dissolved
  3. Wash cells with PBS buffer (no Tris buffer and protein free).
  4. Dilute Zombie NIR™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µL Zombie NIR™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µL for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  5. Incubate the cells at room temperature (or 4°C), in the dark, for 15-30 minutes.
  6. Wash one time with 2 mL BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA.
  7. Continue performing antibody staining procedure as desired.
  8. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation.

No-wash Sequential Staining Protocol:

  1. Wash cells with PBS buffer (no Tris buffer and protein free).
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully  dissolved
  3. Determine the total µL volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µL. Subtract that antibody volume from the 100 µL total staining volume intended for the assay. In the remaining volume, dilute Zombie NIR™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µL of antibody cocktail for a 100 µL total staining volume, use 80 µL of Zombie NIR™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie NIR™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  4. Incubate for 10-15 minutes at RT (or 4°C), protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes.
  5. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet.
  6. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells.
    • Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie NIR™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie NIR™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie NIR™.
Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. McMaster SR, et al. 2015. PLoS One. 10:115725. PubMed
  2. Prado-Garcia H, et al. 2015. Anticancer Res.35:1529. PubMed
  3. Rodriguez-Rodriguez N, et al. 2015. J Immunol. 194:4207. PubMed
  4. Flies DB, et al. 2015. J Immunol. 194:5294. PubMed
Product Citations
  1. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  2. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  3. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  4. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  5. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  6. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  7. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  8. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  9. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  10. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  11. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  12. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  13. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  14. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  15. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  16. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  17. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  18. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  19. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  20. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  21. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  22. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  23. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  24. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  25. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  26. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  27. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  28. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  29. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  30. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  31. Pleuger C, et al. 2022. Elife. 11: . PubMed
  32. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  33. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  34. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  35. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  36. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  37. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  38. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  39. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  40. Rosain J, et al. 2023. Cell. 186:621. PubMed
  41. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  42. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  43. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  44. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  45. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  46. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  47. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  48. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  49. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  50. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  51. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  52. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  53. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  54. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  55. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  56. Zhao Y, et al. 2022. J Neurosci. . PubMed
  57. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  58. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  59. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  60. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  61. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  62. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  63. Han X, et al. 2022. Nutrients. 14:. PubMed
  64. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  65. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  66. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  67. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  68. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  69. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  70. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  71. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  72. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  73. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  74. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  75. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  76. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  77. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  78. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  79. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  80. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  81. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  82. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  83. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  84. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  85. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  86. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  87. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  88. Imai H, et al. 2023. iScience. 26:106822. PubMed
  89. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  90. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  91. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  92. Wu L, et al. 2023. Cell Res. . PubMed
  93. Cansever D, et al. 2023. Nat Immunol. . PubMed
  94. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  95. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  96. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  97. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  98. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  99. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  100. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  101. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  102. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  103. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  104. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  105. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  106. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  107. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  108. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  109. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  110. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  111. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  112. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  113. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  114. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  115. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  116. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  117. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  118. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  119. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  120. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  121. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  122. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  123. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  124. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  125. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  126. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  127. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  128. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  129. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  130. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  131. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  132. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  133. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  134. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  135. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  136. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  137. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  138. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  139. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  140. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  141. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  142. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  143. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  144. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  145. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  146. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  147. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  148. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  149. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  150. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  151. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  152. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  153. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  154. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  155. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  156. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  157. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  158. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  159. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  160. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  161. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  162. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  163. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  164. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  165. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  166. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  167. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  168. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  169. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  170. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  171. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  172. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  173. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  174. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  175. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  176. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  177. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  178. Woodruff MC, et al. 2022. Nature. :. PubMed
  179. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  180. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  181. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  182. Akiyama H, et al. 2020. J Virol. . PubMed
  183. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  184. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  185. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  186. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  187. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  188. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  189. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  190. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  191. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  192. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  193. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  194. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  195. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  196. Mills C, et al. 2022. Cells. 11:. PubMed
  197. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  198. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  199. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  200. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  201. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  202. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  203. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  204. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  205. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  206. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  207. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  208. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  209. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  210. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  211. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  212. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  213. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  214. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  215. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  216. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  217. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  218. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  219. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  220. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  221. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  222. Wang Z, et al. 2021. bioRxiv. . PubMed
  223. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  224. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  225. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  226. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  227. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  228. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  229. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  230. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  231. English KG, et al. 2022. Biomedicines. 10:. PubMed
  232. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  233. Woodruff M, et al. 2020. medRxiv. . PubMed
  234. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  235. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  236. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  237. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  238. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  239. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  240. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  241. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  242. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  243. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  244. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  245. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  246. Popay TM, et al. 2021. Elife. 10: . PubMed
  247. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  248. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  249. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  250. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  251. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  252. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  253. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  254. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  255. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  256. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  257. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  258. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  259. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  260. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  261. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  262. Ito Y, et al. 2018. Cell. 174:636. PubMed
  263. Elias G, et al. 2022. Elife. 11:. PubMed
  264. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  265. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  266. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  267. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  268. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  269. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  270. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  271. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  272. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  273. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  274. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  275. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  276. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  277. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  278. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  279. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  280. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  281. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  283. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  284. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  285. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  286. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  287. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  288. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  289. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  290. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  291. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  292. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  293. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  294. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  295. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  296. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  297. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  298. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  299. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  300. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  301. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  302. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  303. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  304. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  305. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  306. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  307. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  308. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  309. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  310. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  311. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  312. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  313. Wang Z, et al. 2021. Nature. 592:616. PubMed
  314. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  315. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  316. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  317. Dudek M, et al. 2021. Nature. 592:444. PubMed
  318. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  319. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  320. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  321. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  322. He Y, et al. 2022. Cells. 11:. PubMed
  323. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  324. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  325. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  326. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  327. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  328. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  329. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  330. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  331. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  332. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  333. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  334. Wang Z, et al. 2021. Nature. 595:426. PubMed
  335. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  336. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  337. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  338. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  339. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  340. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  341. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  342. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  343. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  344. Korin B, et al. 2020. Sleep. :43. PubMed
  345. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  346. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  347. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  348. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  349. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  350. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  351. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  352. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  353. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  354. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  355. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  356. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  357. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  358. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  359. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  360. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  361. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  362. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  363. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  364. Gaebler C, et al. 2020. bioRxiv. . PubMed
  365. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  366. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  367. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  368. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  369. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  370. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  371. Viant C, et al. 2020. Cell. 183:1298. PubMed
  372. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  373. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  374. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  375. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  376. Sibler E, et al. 2021. Cells. 10:. PubMed
  377. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  378. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  379. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  380. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  381. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  382. Spath S, et al. 2022. iScience. 25:104998. PubMed
  383. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  384. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  385. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  386. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  387. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  388. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed
  389. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  390. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  391. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  392. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  393. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  394. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  395. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  396. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  397. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  398. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  399. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  400. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  401. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  402. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  403. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  404. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  405. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  406. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  407. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  408. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  409. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  410. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  411. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  412. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  413. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  414. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  415. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  416. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  417. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  418. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  419. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  420. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  421. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  422. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  423. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  424. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  425. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  426. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  427. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  428. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  429. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  430. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  431. Pleuger C, et al. 2022. Elife. 11: . PubMed
  432. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  433. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  434. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  435. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  436. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  437. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  438. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  439. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  440. Rosain J, et al. 2023. Cell. 186:621. PubMed
  441. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  442. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  443. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  444. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  445. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  446. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  447. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  448. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  449. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  450. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  451. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  452. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  453. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  454. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  455. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  456. Zhao Y, et al. 2022. J Neurosci. . PubMed
  457. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  458. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  459. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  460. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  461. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  462. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  463. Han X, et al. 2022. Nutrients. 14:. PubMed
  464. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  465. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  466. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  467. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  468. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  469. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  470. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  471. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  472. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  473. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  474. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  475. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  476. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  477. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  478. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  479. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  480. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  481. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  482. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  483. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  484. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  485. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  486. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  487. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  488. Imai H, et al. 2023. iScience. 26:106822. PubMed
  489. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  490. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  491. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  492. Wu L, et al. 2023. Cell Res. . PubMed
  493. Cansever D, et al. 2023. Nat Immunol. . PubMed
  494. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  495. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  496. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  497. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  498. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  499. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  500. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  501. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  502. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  503. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  504. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  505. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  506. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  507. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  508. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  509. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  510. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  511. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  512. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  513. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  514. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  515. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  516. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  517. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  518. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  519. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  520. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  521. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  522. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  523. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  524. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  525. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  526. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  527. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  528. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  529. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  530. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  531. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  532. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  533. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  534. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  535. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  536. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  537. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  538. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  539. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  540. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  541. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  542. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  543. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  544. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  545. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  546. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  547. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  548. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  549. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  550. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  551. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  552. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  553. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  554. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  555. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  556. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  557. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  558. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  559. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  560. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  561. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  562. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  563. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  564. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  565. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  566. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  567. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  568. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  569. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  570. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  571. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  572. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  573. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  574. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  575. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  576. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  577. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  578. Woodruff MC, et al. 2022. Nature. :. PubMed
  579. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  580. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  581. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  582. Akiyama H, et al. 2020. J Virol. . PubMed
  583. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  584. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  585. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  586. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  587. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  588. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  589. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  590. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  591. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  592. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  593. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  594. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  595. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  596. Mills C, et al. 2022. Cells. 11:. PubMed
  597. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  598. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  599. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  600. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  601. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  602. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  603. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  604. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  605. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  606. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  607. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  608. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  609. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  610. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  611. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  612. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  613. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  614. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  615. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  616. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  617. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  618. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  619. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  620. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  621. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  622. Wang Z, et al. 2021. bioRxiv. . PubMed
  623. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  624. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  625. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  626. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  627. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  628. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  629. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  630. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  631. English KG, et al. 2022. Biomedicines. 10:. PubMed
  632. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  633. Woodruff M, et al. 2020. medRxiv. . PubMed
  634. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  635. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  636. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  637. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  638. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  639. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  640. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  641. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  642. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  643. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  644. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  645. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  646. Popay TM, et al. 2021. Elife. 10: . PubMed
  647. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  648. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  649. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  650. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  651. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  652. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  653. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  654. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  655. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  656. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  657. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  658. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  659. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  660. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  661. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  662. Ito Y, et al. 2018. Cell. 174:636. PubMed
  663. Elias G, et al. 2022. Elife. 11:. PubMed
  664. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  665. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  666. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  667. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  668. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  669. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  670. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  671. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  672. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  673. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  674. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  675. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  676. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  677. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  678. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  679. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  680. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  681. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  682. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  683. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  684. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  685. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  686. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  687. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  688. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  689. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  690. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  691. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  692. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  693. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  694. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  695. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  696. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  697. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  698. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  699. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  700. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  701. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  702. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  703. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  704. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  705. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  706. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  707. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  708. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  709. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  710. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  711. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  712. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  713. Wang Z, et al. 2021. Nature. 592:616. PubMed
  714. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  715. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  716. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  717. Dudek M, et al. 2021. Nature. 592:444. PubMed
  718. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  719. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  720. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  721. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  722. He Y, et al. 2022. Cells. 11:. PubMed
  723. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  724. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  725. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  726. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  727. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  728. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  729. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  730. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  731. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  732. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  733. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  734. Wang Z, et al. 2021. Nature. 595:426. PubMed
  735. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  736. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  737. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  738. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  739. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  740. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  741. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  742. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  743. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  744. Korin B, et al. 2020. Sleep. :43. PubMed
  745. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  746. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  747. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  748. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  749. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  750. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  751. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  752. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  753. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  754. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  755. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  756. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  757. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  758. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  759. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  760. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  761. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  762. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  763. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  764. Gaebler C, et al. 2020. bioRxiv. . PubMed
  765. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  766. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  767. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  768. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  769. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  770. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  771. Viant C, et al. 2020. Cell. 183:1298. PubMed
  772. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  773. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  774. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  775. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  776. Sibler E, et al. 2021. Cells. 10:. PubMed
  777. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  778. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  779. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  780. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  781. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  782. Spath S, et al. 2022. iScience. 25:104998. PubMed
  783. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  784. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  785. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  786. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  787. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  788. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed
  789. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  790. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  791. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  792. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  793. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  794. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  795. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  796. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  797. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  798. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  799. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  800. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
NA

Related FAQs

I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
How does the performance of your Zombie dye compare with competitors?

Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.

Can I use methanol/ethanol for fixation after using a Zombie dye?

Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.

Can Zombie be used to determine bacteria, yeast viability?
We have not tested in house bacterial or yeast viability using Zombie dyes. It is not clear whether the difference between surface and intracellular signals will be significantly different in case of non mammalian cells.
Can I use Zombie with cells suspension containing serum?
Serum is full of proteins which will sequester the dye and thereby reducing its effective concentration. The basic rule of thumb with zombie is to titrate it based on your specific condition. Titration also helps reduce the background and spillover into other channels.
Can I use Zombie dyes for microscopy?

Zombie dyes tested in-house for microscopy applications will display data on the product technical datasheet. It should be noted that Zombie dyes may not work for dead cell discrimination in every microscopy application. Important considerations that may impact analysis are determining the signal level that constitutes a dead cell and identifying the proper plane to observe the dead cells.

Why can't I fix my cells prior to using Zombie dyes?

The fixation process can contort and alter the membrane of cells, effectively rendering them dead. Since the ability of the Zombie dyes to stain dead cells is correlated with cell permeability, your results may no longer be a valid representation of dead versus live cells.

Can I use Zombie dyes to detect apoptotic cells?

Yes, Zombie dyes can be used with apoptosis markers, such as Annexin V or Apotracker™ (shown below), to discriminate live, apoptotic, and dead cells.

One day-old C57BL/6 mouse thymocytes were stained with Apotracker™ Tetra Alexa Fluor® 647 and Zombie™ YG581. Zombie-dim/Apotracker™-positive cells are apoptotic, while double-positive cells are dead. Live cells are negative for both markers.

How should I store Zombie dyes?

Store the Zombie dye kit at -20°C upon receipt. Do not open vials until needed. Once DMSO is added, use immediately or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.

Go To Top Version: 7    Revision Date: 12/18/2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account